IL-1 blockade results in dramatic improvement in clinical and laboratory parameters of inflammation in Majeed syndrome, confirming that loss of LPIN2 in these patients leads to autoinflammation via enhanced IL-1β production (46). Here, IL1B is linked to Majeed syndrome.